SparkBox

New Zealands leading angel providing early stage first round financing to ICT start up companies. Apply Now

Mesynthes Limited

assets/Uploads/_resampled/SetWidth120-mesynthes.jpg

Mesynthes develops medical devices for tissue repair and reconstruction based on it's proprietary extracellular matrix technology. The company's major focus is in soft tissue reinforcement and wound care applications. Sparkbox co-invested with angel investor Movac and the Seed Co-Investment Fund of NZVIF in February 2008.

Application Process